🇺🇸 Servent Diskus in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Acute Kidney Injury — 1 report (10%)
2. Asthma — 1 report (10%)
3. Atrial Fibrillation — 1 report (10%)
4. Blood Count Abnormal — 1 report (10%)
5. Bradycardia — 1 report (10%)
6. Bronchial Disorder — 1 report (10%)
7. Chronic Kidney Disease — 1 report (10%)
8. Coronary Artery Disease — 1 report (10%)
9. Cystitis — 1 report (10%)
10. Device Dislocation — 1 report (10%)

Source database →

Frequently asked questions

Is Servent Diskus approved in United States?

Servent Diskus does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Servent Diskus in United States?

Teva Branded Pharmaceutical Products R&D, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.